Skip to main content
Gustavo Kinrys, MD, Psychiatry, Boston, MA

Gustavo D Kinrys MD

Psychopharmacology, Clinical Pharmacology, Clinical Informatics


Medical Director

Join to View Full Profile
  • 50 Staniford StreetSuite 580Boston, MA 02114

  • Phone+1 617-643-6257

  • Fax+1 617-726-6768

Dr. Kinrys is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, 2001 - 2003
  • Mass General Brigham/Massachusetts General Hospital/McLean Hospital
    Mass General Brigham/Massachusetts General Hospital/McLean HospitalChief Residency, Psychiatry, 2000 - 2002
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Psychiatry, 1998 - 2002
  • Faculdade de Medicina da Universidade Federal do Rio de Janeiro
    Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1996

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2024
  • MN State Medical License
    MN State Medical License 2001 - 2002

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Research Paper Tachyphylaxis in Major Depressive Disorder: A Review of the Current State of Research  
    Gustavo Kinrys, Andrew A Nierenberg, George I Papakostas, David Mischoulon, Maurizio Fava, Marlene P Freeman, ScienceDirect

Press Mentions

  • Demand for Virtual Mental Healthcare Is Soaring. Here Are Key Trends on Who Is Using It and Why
    Demand for Virtual Mental Healthcare Is Soaring. Here Are Key Trends on Who Is Using It and WhyOctober 23rd, 2020
  • Teladoc Health Data Shows Broadening Mental Health Care Demand
    Teladoc Health Data Shows Broadening Mental Health Care DemandOctober 21st, 2020
  • Antidepressant with Novel Mechanism of Action Appears Safe and Effective in Phase 1b Clinical Trial
    Antidepressant with Novel Mechanism of Action Appears Safe and Effective in Phase 1b Clinical TrialDecember 8th, 2015

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: